AIM IMMUNOTECH INC. Adjustments to Additional Paid in Capital, Warrant Issued
AIM IMMUNOTECH INC. (AIM) reported Adjustments to Additional Paid in Capital, Warrant Issued of $46.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2022-03-31
- AIM IMMUNOTECH INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2020-03-31 was $46.00K, a 98.35% decline year-over-year.
- AIM IMMUNOTECH INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-12-31 was $0.00.
- AIM IMMUNOTECH INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-09-30 was $0.00.
- AIM IMMUNOTECH INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2019-06-30 was $0.00.
- AIM IMMUNOTECH INC. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $46.00K, a 98.35% decline from fiscal 2019.
- AIM IMMUNOTECH INC. adjustments to additional paid in capital, warrant issued for fiscal 2019 was $2.79M.
- AIM IMMUNOTECH INC. adjustments to additional paid in capital, warrant issued for fiscal 2018 was -$221.00K, a 110.78% decline from fiscal 2017.
- AIM IMMUNOTECH INC. adjustments to additional paid in capital, warrant issued for fiscal 2017 was $2.05M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month as first filed | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month as first filed | Adjustments to Additional Paid in Capital, Warrant Issued 12 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | $46.00K 10-K · filed 2022-03-31 | ||||||
| 2020-03-31 | $46.00K 10-Q · filed 2021-11-15 | $46.00K derived: sum of 2 quarters · filed 2021-11-15 | $46.00K derived: sum of 3 quarters · filed 2021-11-15 | $46.00K derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-K 9 month · filed 2020-03-30 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $0.00 derived: sum of 3 quarters · filed 2021-03-31 | $2.79M 10-K · filed 2020-03-30 | |||
| 2019-09-30 | $0.00 derived: 10-K 9 month − 10-Q 6 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $2.79M 10-K · filed 2021-03-31 | $2.44M 10-Q · filed 2019-11-14 | $2.79M derived: sum of 4 quarters · filed 2021-03-31 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $2.79M 10-Q · filed 2020-08-14 | $2.79M derived: sum of 3 quarters · filed 2020-08-14 | $2.79M derived: sum of 4 quarters · filed 2020-08-14 | |||
| 2019-03-31 | $2.79M 10-Q · filed 2020-05-14 | $2.79M derived: sum of 2 quarters · filed 2020-05-14 | $2.79M derived: sum of 3 quarters · filed 2020-05-14 | $2.35M derived: sum of 4 quarters · filed 2020-05-14 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $0.00 derived: sum of 2 quarters · filed 2020-03-30 | -$442.00K derived: sum of 3 quarters · filed 2020-03-30 | -$221.00K 10-K · filed 2020-03-30 | $221.00K 10-K · filed 2019-04-01 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$442.00K derived: sum of 2 quarters · filed 2019-11-14 | -$221.00K 10-Q · filed 2019-11-14 | $221.00K 10-Q · filed 2018-11-14 | $3.88M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | -$442.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$221.00K 10-Q · filed 2019-08-14 | $221.00K 10-Q · filed 2018-08-14 | $3.88M derived: sum of 3 quarters · filed 2019-08-14 | $3.82M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $221.00K 10-Q · filed 2019-05-15 | $4.32M derived: sum of 2 quarters · filed 2019-05-15 | $4.26M derived: sum of 3 quarters · filed 2019-05-15 | $1.54M derived: sum of 4 quarters · filed 2019-05-15 | |||
| 2017-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $4.04M derived: sum of 2 quarters · filed 2019-04-01 | $1.32M derived: sum of 3 quarters · filed 2019-04-01 | $2.05M 10-K · filed 2019-04-01 | -$2.05M 10-K · filed 2018-03-30 | ||
| 2017-09-30 | -$60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$2.78M derived: sum of 2 quarters · filed 2017-11-14 | -$2.05M 10-Q · filed 2017-11-14 | -$7.28M derived: sum of 4 quarters · filed 2018-03-30 | |||
| 2017-06-30 | -$2.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$1.99M 10-Q · filed 2017-08-14 | -$7.22M derived: sum of 3 quarters · filed 2018-03-30 | ||||
| 2017-03-31 | $734.00K 10-Q · filed 2017-05-15 | -$4.50M derived: sum of 2 quarters · filed 2018-03-30 | |||||
| 2016-12-31 | -$5.23M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | -$2.62M 10-K · filed 2018-03-30 | $2.62M 10-K · filed 2017-03-31 | ||||
| 2016-09-30 | $2.62M 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |